# Dose Escalation Study of SQ109 in Healthy Adult Volunteers

> **NCT00866190** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10 (actual)

## Conditions studied

- TB Multi-drug Resistant

## Interventions

- **DRUG:** SQ109
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00866190
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2011-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866190, "Dose Escalation Study of SQ109 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00866190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*